Found 51 matching trials
Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) PHASE2 This study is a prospective, open-label, multicenter study in previously un...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL N/A This is a prospective, observational, multicenter, cohort study with 400 ne...
Show More Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Learn More & Join Trial
Phase III Study of Tucidinostat in Combination With R-CHOP in Patients With Newly Diagnosed Double-Expressor DLBCL PHASE3 Tucidinostat (formerly known as chidamide) is an oral subtype-selective his...
Show More Location
Peking University Cancer Hospital
Learn More & Join Trial
CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma PHASE2 First-line CAR-T-cell consolidation after an abbreviated induction with 2 c...
Show More Location
University Hospital of Mainz
Learn More & Join Trial
CR-CHOP+X in Previously Untreated DEL PHASE2 This is a prospective, single-arm, open-label phase II clinical trial that ...
Show More Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Learn More & Join Trial
A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping PHASE3 Evaluate the efficacy and safety of C Pola R-CHP+X compared to CR-CHOP in t...
Show More Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, Shanghai, Shanghai
Learn More & Join Trial
Assessing An Oral JAK1 Inhibitor, Golidocitinib, in Patients Who Have Newly Diagnosed Peripheral T-Cell Lymphoma (JACKPOT23) PHASE2 This study will treat patients with newly diagnosed PTCL, who have no prior...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
A Phase I/II Trial of VR-CHOP in Lymphoma Patients PHASE1 This is an open-label (doctors and patients know which drug will be given),...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
Ibrutinib + R-CHOP Followed by Ibrutinib Maintenance PHASE2 This is a prospective, multicenter, single arm, phase II trial in patients ...
Show More Status
Active Not Recruiting
Location
Ospedale di Castelfranco Veneto - Oncoematologia IOV
Learn More & Join Trial
Phase Ⅱ Study of Chidamide in Combination With CHOP in Previously Untreated Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype PHASE2 This is a prospective, open-label, single arm, multicenter clinical study t...
Show More Location
Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University
Learn More & Join Trial